In this episode, Alan is joined by Amil Patel and Nick Nowak, co-founders of Meeko Health, and they discuss the transformative impact of psychedelic therapy, particularly MDMA, on mental health. They talk about their personal experiences with MDMA therapy, which led them to found Meeko Health. They highlight the potential of psychedelic-assisted psychotherapy to condense years of therapy into a few sessions, offering lasting benefits. They also address the challenges of integrating these therapies into traditional healthcare systems, including the high costs of brand-name medications like Spravato compared to generic ketamine. They also emphasize the need for employers to consider innovative mental health solutions and the importance of addressing root causes rather than just symptoms.Listen In!Thank you for listening to this episode of Neuma: The Crossroad Of Science & Enlightenment 

Ver todos los episodios